Artificial intelligence is already taking on an ever greater role in healthcare, from analysing complex medical information and researching diseases to helping scientists speed up the search for new drugs. The bigger question is can the technology dramatically reduce the time it takes to develop effective treatments? Anthropic CEO Dario Amodei believes that possibility is within reach, suggesting that more capable artificial intelligence systems could help humans solve most diseases in the next five to 10 years.
The prediction was made by Amodei in his post on X as a response to suggestions that his remarks regarding the technology were overly preoccupied with its dangerous aspects. The author refuted such ideas by arguing that he has always emphasized both dangers and opportunities that come with the implementation of the technology in question.
2/2 Second, on the messaging around AI. I do not agree that my messaging has been disproportionately negative. In fact it has been about equally balanced between risks and benefits: I’ve written one major essay about each, and even in interviews where I discuss the risks, I…
— Dario Amodei (@DarioAmodei)[August 15, 2026] Moreover, he mentioned his essay titled Machines of Loving Grace and explained that he decided to write it as he felt the industry failed to provide a sufficiently positive perspective on the possible influence of AI on society.
The expectations Amodei has for the future of healthcare can be described as ambitious. According to him, the use of advanced AI will help increase the pace of biological research by at least ten times, thus providing scientists with an opportunity to obtain results that would require 50 to 100 years of work otherwise.
AI Should Come Good on Its Promises #
According to Amodei, earning the public's trust would involve far more than the promotion that AI might potentially develop the capability to cure serious diseases like cancer at some point in the future. Amodei believes that scepticism about the tech industry is an indication of a broader issue of declining trust in big tech companies.
Moreover, Amodei's belief in the capacity of AI is reinforced through personal experience. According to him, his father died of Hepatitis C not long after sofosbuvir and other direct-acting antiviral drugs were developed, which have a cure rate of 95 percent for the disease.
Lastly, Amodei stated that the development in biology and medicine is something that Anthropic is increasingly working on. According to Amodei, these efforts should begin yielding some initial signs of success over the next few months.
ALSO SEE: Top Companies Are Spending Lakhs On AI For Each Employee: What Does The Latest Report Reveal?